test

Tiffany Crowley

@Caligan Partners Lp

Latest period2024 - Q3ReportedManaged Assets$315.473MTotal holdings12
Assets growth rate-26.29%Assets growth rate (2-Q avg)-6.57%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Caligan Partners Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 12 positions.

Assets under management

The assets under management (AUM) of Caligan Partners Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 315.473M in assets, with a quarterly growth rate of -26.29% and a 2-quarter average growth rate of -6.57%. The portfolio is managed by Tiffany Crowley, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
LQDALiquidia Corporation
Recent Activity
Decreased -21.64%
25.74%
$81.186M
8.119M shares@ $10.0 avg price
VRNAVerona Pharma Plc
Recent Activity
Decreased -22.06%
13.11%
$41.339M
1.437M shares@ $28.77 avg price
EXELExelixis Inc
Recent Activity
12.56%
$39.593M
1.526M shares@ $25.96 avg price
EOLSEvolus Inc
Recent Activity
Increased 1.19%
11.27%
$35.535M
2.193M shares@ $16.21 avg price
ANIKAnika Therapeutics Inc
Recent Activity
Decreased -0.06%
11.24%
$35.448M
1.435M shares@ $24.7 avg price
AGIOAgios Pharmaceuticals Inc
Recent Activity
Increased 12.63%
8.17%
$25.757M
579,717 shares@ $44.43 avg price
BCRXBiocryst Pharmaceuticals Inc
Recent Activity
Decreased -43.81%
6.23%
$19.635M
2.584M shares@ $7.6 avg price
YMABY-mabs Therapeutics Inc
Recent Activity
Increased 105.35%
4.99%
$15.718M
1.195M shares@ $13.16 avg price
MLYSMineralys Therapeutics Inc
Recent Activity
Increased 31.57%
3.77%
$11.882M
981,155 shares@ $12.11 avg price
IMABI Mab
Recent Activity
Increased 3.7%
1.38%
$4.339M
3.499M shares@ $1.24 avg price